GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $294,000 | -15.8% | 6,752 | -15.8% | 0.00% | 0.0% |
| Q1 2022 | $349,000 | -16.9% | 8,022 | -15.7% | 0.00% | -20.0% |
| Q4 2021 | $420,000 | +66.0% | 9,521 | +43.6% | 0.01% | +66.7% |
| Q3 2021 | $253,000 | -27.1% | 6,632 | -23.9% | 0.00% | -25.0% |
| Q2 2021 | $347,000 | +30.9% | 8,710 | +17.3% | 0.00% | 0.0% |
| Q1 2021 | $265,000 | -16.7% | 7,428 | -14.1% | 0.00% | 0.0% |
| Q4 2020 | $318,000 | -28.9% | 8,646 | -27.1% | 0.00% | -42.9% |
| Q3 2020 | $447,000 | -18.6% | 11,868 | -11.8% | 0.01% | -30.0% |
| Q2 2020 | $549,000 | -10.1% | 13,454 | -16.5% | 0.01% | -16.7% |
| Q1 2020 | $611,000 | -18.2% | 16,122 | +1.4% | 0.01% | 0.0% |
| Q4 2019 | $747,000 | +12.3% | 15,892 | +2.1% | 0.01% | +20.0% |
| Q3 2019 | $665,000 | +15.3% | 15,570 | +7.9% | 0.01% | +11.1% |
| Q2 2019 | $577,000 | -11.5% | 14,425 | -7.5% | 0.01% | -18.2% |
| Q1 2019 | $652,000 | +3.7% | 15,594 | -5.2% | 0.01% | -8.3% |
| Q4 2018 | $629,000 | -18.2% | 16,457 | -14.0% | 0.01% | -14.3% |
| Q3 2018 | $769,000 | -0.6% | 19,136 | -0.3% | 0.01% | -6.7% |
| Q2 2018 | $774,000 | +50.9% | 19,190 | +46.1% | 0.02% | +50.0% |
| Q1 2018 | $513,000 | +30.2% | 13,131 | +18.4% | 0.01% | +25.0% |
| Q4 2017 | $394,000 | +579.3% | 11,094 | +672.0% | 0.01% | +700.0% |
| Q3 2017 | $58,000 | -88.0% | 1,437 | -87.2% | 0.00% | -90.9% |
| Q2 2017 | $484,000 | +3.9% | 11,232 | +1.5% | 0.01% | 0.0% |
| Q1 2017 | $466,000 | -60.7% | 11,062 | -56.9% | 0.01% | -69.4% |
| Q1 2015 | $1,185,000 | +20.9% | 25,674 | +12.0% | 0.04% | +28.6% |
| Q4 2014 | $980,000 | +12.4% | 22,930 | +20.8% | 0.03% | -3.4% |
| Q3 2014 | $872,000 | +12.5% | 18,975 | +30.9% | 0.03% | +16.0% |
| Q2 2014 | $775,000 | +8.2% | 14,497 | +8.1% | 0.02% | +8.7% |
| Q1 2014 | $716,000 | -8.8% | 13,408 | -8.9% | 0.02% | -14.8% |
| Q4 2013 | $785,000 | +4.9% | 14,712 | -1.3% | 0.03% | -3.6% |
| Q3 2013 | $748,000 | -7.3% | 14,912 | -7.6% | 0.03% | -12.5% |
| Q2 2013 | $807,000 | – | 16,147 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |